
Retension Pharmaceuticals, Inc.
Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Retension Pharmaceuticals is a clinical-stage pharmaceutical company developing treatments for ophthalmic and other medical conditions. The company is headquartered in McLean, Virginia.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Keller Eric L.CHIEF EXECUTIVE OFFICER | Buy | $250K | 20,800at $12.00 | Oct 13, 2026 |
| BERGER FRANKLIN MDirector | Buy | $120K | 10,000at $12.00 | Oct 13, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable RTSN activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.